Allogene Therapeutics's top three insider shareholders as of May 30, 2026 are David D Chang (President And Ceo, 5.15Mn shares), Geoffrey M. Parker (Chief Financial Officer, 1.25Mn shares), Eric Thomas Schmidt (Chief Financial Officer, 862.44K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Vicki L Sato | - | 162,575 | 0 | 07 Jun, 2024 |
| Joshua A Kazam | - | 350,763 | 0 | 22 Dec, 2025 |
| Earl Martin Douglas | Svp, General Counsel | 564,948 | 0 | 04 Feb, 2026 |
| Geoffrey M. Parker | Chief Financial Officer | 1,252,795 | 0 | 04 Feb, 2026 |
| David D Chang | President And Ceo | 5,150,599 | 0 | 18 Mar, 2026 |
| Rafael Amado | Evp Of Rd | 541,946 | 0 | 11 Oct, 2022 |
| Timothy L. Moore | Chief Technical Officer | 250,713 | 0 | 05 Feb, 2025 |
| Owen N. Witte | - | 292,832 | 0 | 15 Jun, 2023 |
| Eric Thomas Schmidt | Chief Financial Officer | 862,439 | 0 | 24 Mar, 2023 |
| Deborah M. Messemer | - | 107,431 | 0 | 12 Jun, 2025 |
| Alison Moore | Chief Technical Officer | 672,731 | 0 | 24 Mar, 2023 |
| Veer Bhavnagri | General Counsel | 556,049 | 0 | 16 Mar, 2023 |
| Annie Yoshiyama | Svp, Finance | 124,517 | 0 | 23 Apr, 2026 |
| Stephen Mayo | - | 25,328 | 0 | 09 Aug, 2023 |
| Zachary Roberts | Evp Of Rd | 581,166 | 0 | 04 Feb, 2026 |
| Lillian Smith | Vp, Corporate Counsel | 140,390 | 0 | 05 Apr, 2023 |
| Yinlin Jack Chen | Svp, Finance | 88,881 | 0 | 14 Aug, 2023 |
| Benjamin Machinas Beneski | Svp, Chief Technical Officer | 195,338 | 0 | 02 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Apr, 2026 | Annie Yoshiyama | Common Stock | D | 9,586 | $2.31 | 124,517 | D | S |
| 21 Apr, 2026 | Annie Yoshiyama | Common Stock | D | 9,586 | $2.31 | 124,517 | D | S |
| 31 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 2,867 | $2.50 | 195,338 | D | S |
| 31 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 2,867 | $2.50 | 195,338 | D | S |
| 31 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 2,867 | $2.50 | 195,338 | D | S |
| 16 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 4,835 | $2.47 | 198,205 | D | S |
| 16 Mar, 2026 | David D Chang | Common Stock | D | 47,763 | $2.47 | 5,150,599 | D | S |
| 16 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 4,835 | $2.47 | 198,205 | D | S |
| 16 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 4,835 | $2.47 | 198,205 | D | S |
| 02 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,132 | $2.60 | 203,040 | D | S |
| 02 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,132 | $2.60 | 203,040 | D | S |
| 02 Mar, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,132 | $2.60 | 203,040 | D | S |
| 02 Feb, 2026 | Annie Yoshiyama | Common Stock | D | 4,167 | $1.72 | 130,322 | D | S |
| 02 Feb, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,549 | $1.73 | 210,172 | D | S |
| 02 Feb, 2026 | Earl Martin Douglas | Common Stock | D | 22,900 | $1.76 | 564,948 | D | S |
| 02 Feb, 2026 | Annie Yoshiyama | Common Stock | D | 4,167 | $1.72 | 130,322 | D | S |
| 02 Feb, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,549 | $1.73 | 210,172 | D | S |
| 02 Feb, 2026 | Zachary Roberts | Common Stock | D | 35,700 | $1.77 | 581,166 | D | S |
| 02 Feb, 2026 | Earl Martin Douglas | Common Stock | D | 22,900 | $1.76 | 564,948 | D | S |
| 02 Feb, 2026 | Zachary Roberts | Common Stock | D | 35,700 | $1.77 | 581,166 | D | S |